Answers are grounded in this paper and cite their sources.
Background: Surgical management of primary and secondary liver malignancies has evolved from open resection toward minimally invasive and robotic approaches within multidisciplinary pathways integrating surgery, systemic therapy, and, in selected patients, liver transplantation. Hepatocellular carcinoma, cholangiocarcinoma, and colorectal liver metastases each require distinct decisions regarding indication, timing, extent of resection, and surgical strategy. Methods: This narrative review re-elaborates the scientific content presented during the session “Hepatobiliary Surgery: Surgical Choices and Multidisciplinary Vision,” held at the 44th National Congress of the Italian Association of Hospital Surgeons (ACOI) (Palermo, Italy, 24–27 May 2026). The complete session transcript constituted the primary source and was synthesized according to the standardized editorial methodology described by Molteni et al. Results: Major topics included robotic surgery, multimodal treatment strategies, resection-versus-transplantation in hepatocellular carcinoma, lymphadenectomy and extent of resection in cholangiocarcinoma, and treatment timing and minimally invasive surgery for colorectal liver metastases. Across all settings, technological innovation expanded surgical options while reinforcing the need for multidisciplinary decision-making and oncological appropriateness. Conclusions: Management of liver malignancies requires multidisciplinary integration, where appropriate patient selection and oncological principles remain paramount. Robotic surgery extends minimally invasive possibilities but complements, rather than replaces, sound surgical judgment.
No takes yet. Share an insight, caveat, or question.
Sagnotta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: